Manulife (Manufacturers Life Insurance)
BBNX

Manulife (Manufacturers Life Insurance)’s Beta Bionics BBNX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$106K Sell
10,610
-35,829
-77% -$530K ﹤0.01% 2611
2025
Q4 		$1.47M Buy
46,439
+4,035
+10% +$108K ﹤0.01% 1668
2025
Q3 		$843K Buy
42,404
+18,846
+80% +$331K ﹤0.01% 1946
2025
Q2 		$343K Buy
23,558
+2,205
+10% +$31.2K ﹤0.01% 2332
2025
Q1 		$261K Buy
+21,353
New +$398K ﹤0.01% 2388

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Manulife (Manufacturers Life Insurance)'s BBNX Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Beta Bionics (BBNX) stake by 77% in Q1 2026, selling an estimated $530K and leaving 10,610 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #2611.

Manulife (Manufacturers Life Insurance) first reported a position in BBNX in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.47M in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 10,610 shares of Beta Bionics worth $106K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 35,829 Beta Bionics shares in Q1 2026, an estimated $530K.
  • Beta Bionics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2611 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Beta Bionics in Q1 2025 and has held it in 5 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Beta Bionics position peaked at $1.47M in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.